Chronic obstructive pulmonary disease (COPD) is a leading cause of morbidity and mortality worldwide. Exacerbations are associated with accelerated lung function decline, reduced quality of life, and increased healthcare utilization. While dual bronchodilator therapy remains a cornerstone of COPD management, some patients continue to experience frequent exacerbations despite optimized treatment. Identifying the most appropriate treatment strategy in these individuals is critical to improving long-term outcomes. Here is a quick question on evidence-based management of high-risk COPD!
(Scroll down to answer the question) ##Reference## Lipson DA, Barnhart F, Brealey N, et al. Once-Daily Single-Inhaler Triple versus Dual Therapy in Patients with COPD. N Engl J Med. 2018 May 3;378(18):1671-1680. doi:10.1056/NEJMoa1713901.## ##Disclaimer## The content provided on Docplexus is intended for…
